当前位置: 首页 JCRQ2 期刊介绍(非官网)
Diabetes & Metabolic Syndrome-clinical Research & Reviews

Diabetes & Metabolic Syndrome-clinical Research & Reviews

SCIE

国际简称:DIABETES METAB SYND  参考译名:糖尿病与代谢综合征-临床研究与评论

  • 中科院分区

    3区

  • CiteScore分区

    Q1

  • JCR分区

    Q2

基本信息:
ISSN:1871-4021
E-ISSN:1878-0334
是否OA:未开放
是否预警:否
TOP期刊:否
出版信息:
出版地区:ENGLAND
出版商:Elsevier
出版语言:English
出版周期:6 issues/year
研究方向:ENDOCRINOLOGY & METABOLISM
评价信息:
影响因子:4.4
CiteScore指数:8.6
SJR指数:1.17
SNIP指数:1.245
发文数据:
Gold OA文章占比:21.07%
研究类文章占比:73.61%
年发文量:72
自引率:0.02
开源占比:0.012
出版撤稿占比:
出版国人文章占比:0
OA被引用占比:0.0018...
英文简介 期刊介绍 CiteScore数据 中科院SCI分区 JCR分区 发文数据 常见问题

英文简介Diabetes & Metabolic Syndrome-clinical Research & Reviews期刊介绍

Diabetes&Metabolic Syndrome clinical Research&Reviews is an academic journal focusing on clinical research and review in the field of diabetes and metabolic syndrome. It aims to provide a platform for medical researchers, clinicians and public health experts worldwide to exchange and share the latest research results, clinical experience and treatment methods. As an international academic journal, it covers all aspects of diabetes and metabolic syndrome, including etiology, pathophysiology, diagnostic methods, drug treatment, non drug treatment, complication management and preventive measures. It not only focuses on the latest progress in basic research, but also focuses on the application and innovation in clinical practice. In terms of content, he mainly published original research papers, systematic reviews, case reports, clinical trials, meta-analysis, policy forums, educational reviews and other types of articles, covering various fields of diabetes and metabolic syndrome, providing readers with a comprehensive and in-depth understanding.

期刊简介Diabetes & Metabolic Syndrome-clinical Research & Reviews期刊介绍

《Diabetes & Metabolic Syndrome-clinical Research & Reviews》是一本医学优秀杂志。致力于发表原创科学研究结果,并为医学各个领域的原创研究提供一个展示平台,以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述,从广泛的视角提供当前感兴趣的研究主题的新见解,或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单,目前已被权威数据库SCIE收录,得到了广泛的认可。

该期刊投稿重要关注点:

Cite Score数据(2026年6月最新版)Diabetes & Metabolic Syndrome-clinical Research & Reviews Cite Score数据

  • CiteScore:8.6
  • SJR:1.17
  • SNIP:1.245
学科类别 分区 排名 百分位
大类:Medicine 小类:Internal Medicine Q1 28 / 179

84%

大类:Medicine 小类:Endocrinology, Diabetes and Metabolism Q1 39 / 250

84%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础,针对的是前四年发表的论文的引文。CiteScore的意义在于,它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法,而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Diabetes & Metabolic Syndrome-clinical Research & Reviews 中科院分区

《新锐期刊分区表》(2026年3月发布) 综述期刊:否 Top期刊:否
大类学科 分区 小类学科 分区
医学 3区 ENDOCRINOLOGY & METABOLISM 内分泌学与代谢 3区
期刊分区表(2025年3月升级版) 综述期刊:否 Top期刊:否
大类学科 分区 小类学科 分区
医学 3区 ENDOCRINOLOGY & METABOLISM 内分泌学与代谢 4区

中科院分区表 是以客观数据为基础,运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据,得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次,类似于“优、良、及格”等。最开始,这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Diabetes & Metabolic Syndrome-clinical Research & Reviews JCR分区

2025-2026年最新版
按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ENDOCRINOLOGY & METABOLISM ESCI Q2 59 / 198

70.5

学科:ENDOCRINOLOGY & METABOLISM ESCI Q2 84 / 198

57.83

2023-2024年最新版
按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ENDOCRINOLOGY & METABOLISM ESCI Q1 39 / 186

79.3

学科:ENDOCRINOLOGY & METABOLISM ESCI Q1 13 / 186

93.28

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异,此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此,JCR将期刊按照学科门类和影响因子分为不同的分区,这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

本刊中国学者近年发表论文

  • 1、Predictive effect of FT3 levels on normal thyroid function in patients with type 2 diabetic kidney disease: A cross-sectional analysis of inpatients in Chin

    Author: Zhong, Weili; Yue, Jinfeng; Zhang, Chunhuo; Niu, Shuying; Zhao, Yanli; Zhao, Shangshuang; Yu, Ying; Li, Jing; Han, Jun

    Journal: DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS. 2026; Vol. 20, Issue 3, pp. -. DOI: 10.1016/j.dsx.2026.103400

  • 2、People living with diabetes with sodium-glucose cotransporter-2 inhibitors use are at an increased risk of future total knee joint replacemen

    Author: Hu, Wei-Syun; Lin, Cheng-Li

    Journal: DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS. 2026; Vol. 20, Issue 3, pp. -. DOI: 10.1016/j.dsx.2026.103402

  • 3、Efficacy and safety of finerenone in the treatment of primary aldosteronism: A prospective clinical stud

    Author: Li, Shuo; Zhang, Yifan; Liu, Xuan; Chai, Yun; Jia, Hongwei; Shu, Hua; Fan, Yuxin; Ding, Li; Liu, Ming

    Journal: DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS. 2026; Vol. 20, Issue 1, pp. -. DOI: 10.1016/j.dsx.2025.103369

  • 4、Prediction of retinopathy risk: A prospective cohort study in Chin

    Author: Xu, Xiaohan; Wang, Duolao; Alam, Uazman; Qiu, Shanhu; Ding, Yuzhi; Sun, Zilin; Garrib, Anupam

    Journal: DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS. 2025; Vol. 19, Issue 5, pp. -. DOI: 10.1016/j.dsx.2025.103251

  • 5、Association between metabolically healthy obesity and atrial fibrillation: A systematic review and meta-analysis of longitudinal studie

    Author: Liu, Xiao; Ling, Jitao; Wu, Yifan; Zhao, Huilei; Hu, Yuzhe; Yan, Zhiwei; Zhu, Wengen; Yu, Peng; Wang, Jinfeng; Zhang, Yuling; Bucci, Tommaso; Lip, Gregory Y. H

    Journal: DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS. 2025; Vol. 19, Issue 4, pp. -. DOI: 10.1016/j.dsx.2025.103228

  • 6、Letter to the Editor regarding Global research trends and hotspots in gestational diabetes and long-term cardiovascular health: A bibliometric analysis

    Author: Rao, Hao-Han; Guo, Feng; Tian, Jie

    Journal: DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS. 2025; Vol. 19, Issue 2, pp. -. DOI: 10.1016/j.dsx.2025.103190

  • 7、The predictive value of estimated glucose disposal rate for all-cause and cardiovascular mortality in the US non-diabetic population aged ≥60 years: A population-based cohort stud

    Author: Zhu, Botao; Cao, Chenghui; Liu, Wenwu; Liu, Yuxuan; Luo, Yonghong; Peng, Daoquan

    Journal: DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS. 2025; Vol. 19, Issue 1, pp. -. DOI: 10.1016/j.dsx.2024.103182

  • 8、Decoding the disproportionate risk factor landscape of global type 2 diabetes burden in adults: An attribution analysis from 1990 to 205

    Author: Huang, Yue; Wang, Jingxuan; Xu, Lan; Feng, Nannan; Du, Xihao; Chen, Meng; Li, Yiyuan; Yang, Guangrui; Wang, Hui; Zhong, Victor W.

    Journal: DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS. 2025; Vol. 19, Issue 1, pp. -. DOI: 10.1016/j.dsx.2024.103181

投稿常见问题